← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2004Last known activity
Apr 20, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 3 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (3)
- NCT05863234Lead sponsorPhase 1/Phase 2Apr 20, 2023
- NCT05120349Overall official - principal investigatorPhase 3Jan 30, 2022
- NCT00221104Overall official - principal investigatorPhase 3Mar 1, 2004
Details
- Last known activity
- Apr 20, 2023